CAS: 116209-55-3; (2S)-1-[4-[2-(Cyclopropylmethoxy)Ethyl]Phenoxy]-3-(Propan-2-Ylamino)Propan-2-Ol,Hydrochloride

该化合物是一种主要用于治疗青光眼和眼部高血压的选择性乙型-1肾上腺对抗物,作为乙型阻塞剂的一员,通过减少水性幽默生产来减少内腔压力.该物质的特点在于对乙型-1受体的高度选择性,这可以最大限度地减少与非选择性乙型阻塞体有关的潜在副作用.Levobetalogol通常作为一种眼滴溶液来施用,其药用植物动力涉及快速吸收和相对较短的半衰期,需要每天多剂量来有效管理眼压.盐盐的形态在水溶液中强化其溶性与稳定性,使之适合眼部配方.常见副作用可能包括:眼部不适,眼干燥或透视,而系统吸收则可能导致心血管效应,尽管由于局部应用,这些作用并不常见.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9757463-B2
    优先权日:2012-06-15
    标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
    发明人:HARTH EVA M; BEEZER DAIN B; LI GUANGZHAO; SPEARS BENJAMIN R; STEVENS DAVID M
    权利人:UNIV VANDERBILT
    摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:CN-1651379-A
    优先权日:2004-12-03
    标 题 :A new process for the synthesis of 4-[2-(cyclopropylmethoxy)ethyl]phenol

    专利号:US-9745419-B2
    优先权日:2014-01-24
    标 题 :Aqueous polyglycidol synthesis with ultra-low branching
    发明人:HARTH EVA M; SPEARS BENJAMIN R
    权利人:UNIV VANDERBILT
    摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for a variety of applications, including, but not limited to, drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:WO-2024097977-A1
    优先权日:2022-11-04
    标题:Silk nanoparticle synthesis: tuning size, dispersity, and surface chemistry for drug delivery
    发明人:SHAIDANI SAWNAZ; FALCUCCI THOMAS; FOSTER OLIVIA; SAHOO JUGAL KISHORE; HASTURK ONUR; KAPLAN DAVID L; JACOBUS CHARLOTTE S
    权利人:TUFTS COLLEGE
    摘要:Methods disclosed herein relate to generating silk nanoparticles with a low polydispersity index (PDI). Methods include adding a silk solution dropwise into a volatile solvent that is miscible with water, thereby forming a precipitate-bearing solution and applying shear forces to the precipitate-bearing solution for a length of time sufficient to achieve evaporation of at least 95% of the volatile solvent, thereby producing a population of silk fibroin nanoparticles in water having a polydispersity index (PDI) of 0.35 or less, including but not limited to, a PDI of 0.330 or less, 0.325 or less, 0.315 or less, 0.310 or less, 0.30 or less, 0.275 or less, 0.250 or less, 0.225 or less, or 0.200 or less. Parameters related to silk fibroin molecular weight, silk fibroin concentration, shear force application, and temperature may all be modified to achieve silk nanoparticles of a particular size exhibiting particular PDIs.

    专利号:US-2016206743-A1
    优先权日:2012-06-15
    标题 :Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures

    专利号:US-2014005278-A1
    优先权日:2012-06-15
    标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Quaranta L, Turano R, Pizzolante T. Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension. Clin Ophthalmol. 2007 Jun;1(2):93-7.
    2: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Nov;29(9):625-55.

    合成参考文献


    参考文献:10.1007/978-3-031-61073-8_15
    摘要:Wang C, Abbasian J. Medical Therapy of Childhood Glaucoma. 2024. In: Childhood Glaucoma.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知